Edesa Biotech (EDSA) Revenue (2013 - 2020)

Edesa Biotech has disclosed Revenue across 8 years of filings, most recently posting $500.0 for Q3 2020.

• In Q3 2020, Revenue changed N/A year-over-year to $500.0; the TTM figure through Jun 2021 stood at $500.0 (down 99.85% YoY), while the FY2020 annual figure was $328801.0, down 19.97% from the prior year.
• Revenue came in at $500.0 for Q3 2020 at Edesa Biotech, down from $109985.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $326335.0 in Q1 2016 to a low of $500.0 in Q2 2019.
• Average Revenue over 5 years is $98660.9, with a median of $64052.0 recorded in 2018.
• Year-over-year, Revenue plunged 98.96% in 2017 and surged 21897.0% in 2020.
• Over 5 years, Revenue stood at $141856.0 in 2016, then slumped by 85.56% to $20487.0 in 2017, then jumped by 164.84% to $54257.0 in 2018, then surged by 98.68% to $107800.0 in 2019, then slumped by 99.54% to $500.0 in 2020.
• Per Business Quant data, the three most recent Revenue figures were $500.0 in Q3 2020, $109985.0 in Q2 2020, and $110516.0 in Q1 2020.